118 related articles for article (PubMed ID: 14768049)
1. Regulation of autoimmune diabetes by non-islet-specific T cells - a role for the glucocorticoid-induced TNF receptor.
Suri A; Shimizu J; Katz JD; Sakaguchi S; Unanue ER; Kanagawa O
Eur J Immunol; 2004 Feb; 34(2):447-54. PubMed ID: 14768049
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
3. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
[TBL] [Abstract][Full Text] [Related]
4. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
5. Tolerance mechanisms in murine autoimmune diabetes induced by anti-ICAM-1/LFA-1 mAb and anti-CD8 mAb.
Chowdhury SA; Nagata M; Yamada K; Nakayama M; Chakrabarty S; Jin Z; Kotani R; Yokono K
Kobe J Med Sci; 2002 Dec; 48(5-6):167-75. PubMed ID: 12657834
[TBL] [Abstract][Full Text] [Related]
6. Lymphoid hyperplasia, CD45RBhigh to CD45RBlow T-cell imbalance, and suppression of Type I diabetes mellitus result from TNF blockade in NOD-->NOD-scid adoptive T cell transfer.
Brown GR; Silva MD; Thompson PA; Beutler B
Diabetologia; 1998 Dec; 41(12):1502-10. PubMed ID: 9867218
[TBL] [Abstract][Full Text] [Related]
7. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
Balasa B; Van Gunst K; Sarvetnick N
Clin Immunol; 2000 May; 95(2):93-8. PubMed ID: 10779402
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
Balasa B; Lee J; Sarvetnick N
Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
[TBL] [Abstract][Full Text] [Related]
9. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
Wilson SS; DeLuca D
J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
[TBL] [Abstract][Full Text] [Related]
10. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
11. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha receptor 1 (p55) on islets is necessary for the expression of LIGHT on diabetogenic T cells.
Pakala SV; Ilic A; Chen L; Sarvetnick N
Clin Immunol; 2001 Aug; 100(2):198-207. PubMed ID: 11465949
[TBL] [Abstract][Full Text] [Related]
13. Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-kappaB.
Stephens LA; Thomas HE; Kay TW
J Autoimmun; 1997 Jun; 10(3):293-8. PubMed ID: 9218757
[TBL] [Abstract][Full Text] [Related]
14. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
[TBL] [Abstract][Full Text] [Related]
15. On the pathogenicity of autoantigen-specific T-cell receptors.
Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
[TBL] [Abstract][Full Text] [Related]
16. Peptide specific amelioration of T cell mediated pathogenesis in murine type 1 diabetes.
Judkowski V; Rodriguez E; Pinilla C; Masteller E; Bluestone JA; Sarvetnick N; Wilson DB
Clin Immunol; 2004 Oct; 113(1):29-37. PubMed ID: 15380527
[TBL] [Abstract][Full Text] [Related]
17. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
Qin HY; Chaturvedi P; Singh B
Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
[TBL] [Abstract][Full Text] [Related]
18. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
Glinka Y; Chang Y; Prud'homme GJ
Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow is a preferential homing site for autoreactive T-cells in type 1 diabetes.
Li R; Perez N; Karumuthil-Melethil S; Vasu C
Diabetes; 2007 Sep; 56(9):2251-9. PubMed ID: 17596402
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
